Correction to: Cancer Gene Therapy

https://doi.org/10.1038/s41417-021-00316-6

A mistake in the beta-actin control in Fig. 4B and an unnecessary inclusion of an extra Erk1/2 control sample in Fig. 6A, B were made in the initial publication. None of these mistakes affects the main finding and conclusion of the publication.

Fig. 4
figure 4

▓.

Fig. 6
figure 6

▓.

Specifically

In Fig. 4B, during the step of original film scanning (we have three different exposures of each gel/membrane), organizing and copying-and-pasting different images to form the Fig. 4B, careless mistakes were made in re-using two different exposures of Akt2 for beta-actin, instead of beta-actin blots themselves. Corrections have now been made to replace them with the original beta-actin blots.

In Fig. 6A, B, the original experiment of anti-Erk1/2 immunoblots had a seventh lane loaded with total lysates from WT MDA-MB-231 cells, which was unrelated to this publication. We mistakenly included all seven samples (panels b and f), while other control markers in the same experiment, Akt2, Stat3 and beta-actin had six samples. Correction has now been made to remove the seventh sample from the anti-Erk1/2 immunoblots.

The original article has been corrected.